Related Experiment Video
Updated: Jul 18, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Pleiotropic effects of the non-calcium phosphate binder sevelamer
I G Nikolov1, N Joki, J Maizel
1Inserm Unit 507, Necker Hospital, University of Paris V, Paris, France.
Insights
Chronic kidney disease (CKD) patients face rising adverse outcomes, especially cardiovascular mortality. Sevelamer hydrochloride effectively controls hyperphosphatemia without calcium overload, offering additional benefits like lipid correction.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pharmacology
Background:
- Chronic kidney disease (CKD) is a growing global health concern.
- Cardiovascular mortality is significantly increased in CKD patients.
- Hyperphosphatemia is a common and serious complication in advanced CKD.
Purpose of the Study:
- To evaluate sevelamer hydrochloride as a phosphate binder in CKD patients.
- To assess the efficacy of sevelamer hydrochloride in managing hyperphosphatemia.
- To explore potential pleiotropic effects of sevelamer hydrochloride beyond phosphate control.
Main Methods:
- Clinical studies and experimental research were reviewed.
- Efficacy of sevelamer hydrochloride was compared to calcium-based phosphate binders.
- Analysis included effects on phosphate levels, calcium load, lipid profiles, and uremic toxin clearance.
Main Results:
- Sevelamer hydrochloride effectively controls hyperphosphatemia in CKD.
- Unlike calcium-based binders, sevelamer does not increase calcium load.
- Sevelamer hydrochloride demonstrates pleiotropic effects, including lipid normalization and uremic toxin reduction.
Conclusions:
- Sevelamer hydrochloride is a safe and effective treatment for hyperphosphatemia in CKD.
- Its non-calcium-based formulation avoids calcium overload risks.
- Sevelamer offers additional cardiovascular and renal protective benefits through its pleiotropic actions.
Abstract:
The number of chronic kidney disease (CKD) patients and related adverse outcomes has dramatically increased worldwide in the past decade. Therefore, numerous experimental and clinical studies have recently addressed the underlying mechanisms, in particular the marked increase in cardiovascular mortality. Hyperphosphatemia is a major problem in these patients with advanced stage of CKD. Its control by calcium-containing phosphate binders is effective, but at the price of potentially noxious calcium overload. Sevelamer hydrochloride is a phosphate binder that offers an effective control of hyperphosphatemia as calcium-rich binders but without increase of calcium load. Beyond the control of phosphate, sevelamer seems to exert pleiotropic effects which include the correction of lipid abnormalities and the clearance of some uremic toxins.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Introduction to Electrolytes
Role of Sodium
One...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

